Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302Fanying Meng, Charles P. Hart, James Evans et al.|Molecular Cancer Therapeutics|2011Cited by 206
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, Richard B. Lock, Tara Pritchard et al.|Clinical Cancer Research|2019Cited by 53
Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancerJessica D. Sun, Charles P. Hart, Qian Liu et al.|Cancer Biology & Therapy|2015Cited by 51
Potent Antitubulin Tumor Cell Cytotoxins Based on 3-Aroyl IndazolesMark Matteucci, Xiaohong Cai, Fanying Meng et al.|Journal of Medicinal Chemistry|2007Cited by 50
Effect of hypophosphatemia on the withdrawal of mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary diseaseYuliang Zhao, GE YANG, Fanying Meng et al.|Biomedical Reports|2016Cited by 47